ISIN | IE00BKWQ0H23 |
---|---|
Valor Number | 24767202 |
Bloomberg Global ID | |
Fund Name | SPDR MSCI Europe Health Care UCITS ETF EUR |
Fund Provider |
State Street Global Advisors
Kalanderplatz 5, 8045 Zürich E-Mail: spdrsswitzerland@ssga.com Web: www.ssga.com spdrsswitzerland@ssga.com (ETF Business) |
Fund Provider | State Street Global Advisors |
Representative in Switzerland |
State Street Bank GmbH, München, Zweigniederlassung Zürich Zürich Phone: +41 44 560 50 00 |
Distributor(s) | State Street Global Advisors |
Asset Class | Equities |
EFC Category | |
Distribution Policy | Accumulation |
Home Country | Ireland |
Issuing Condition | Combination of issuing commission charged by the fund management company and transaction fee charged by the fund |
Redemption Condition | Combination of redemption commission charged by the fund management company and transaction fee charged by the fund |
Investment Strategy *** | The investment objective of the Fund is to track the performance of European large and midsized companies in the Health Care sector. |
Peculiarities |
Current Price * | 202.36 EUR | 16.05.2025 |
---|---|---|
Previous Price * | 199.99 EUR | 15.05.2025 |
52 Week High * | 247.60 EUR | 30.08.2024 |
52 Week Low * | 182.04 EUR | 09.04.2025 |
NAV * | 202.36 EUR | 16.05.2025 |
Issue Price * | ||
Redemption Price * | ||
Closing Price * | ||
Indicative Minimum Price | ||
Fund Assets *** | 664,628,964 | |
Unit/Share Assets *** | 664,628,964 | |
Trading Information SIX |
YTD Performance | -3.50% |
31.12.2024 - 16.05.2025
31.12.2024 16.05.2025 |
---|---|---|
YTD Performance (in CHF) | -4.01% |
31.12.2024 - 16.05.2025
31.12.2024 16.05.2025 |
1 month | +3.89% |
16.04.2025 - 16.05.2025
16.04.2025 16.05.2025 |
3 months | -9.52% |
17.02.2025 - 16.05.2025
17.02.2025 16.05.2025 |
6 months | -4.15% |
18.11.2024 - 16.05.2025
18.11.2024 16.05.2025 |
1 year | -10.62% |
16.05.2024 - 16.05.2025
16.05.2024 16.05.2025 |
2 years | -2.22% |
16.05.2023 - 16.05.2025
16.05.2023 16.05.2025 |
3 years | +6.67% |
16.05.2022 - 16.05.2025
16.05.2022 16.05.2025 |
5 years | +22.03% |
18.05.2020 - 16.05.2025
18.05.2020 16.05.2025 |
Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date |
Roche Holding AG | 13.57% | |
---|---|---|
Novartis AG Registered Shares | 13.25% | |
AstraZeneca PLC | 13.09% | |
Novo Nordisk AS Class B | 12.58% | |
Sanofi SA | 7.30% | |
Essilorluxottica | 5.03% | |
GSK PLC | 4.84% | |
Lonza Group Ltd | 3.05% | |
Alcon Inc | 2.86% | |
Haleon PLC | 2.68% | |
Last data update | 30.04.2025 |
TER | |
---|---|
TER date | |
Performance Fee *** | |
PTR | |
Max. Management Fee *** | 0.18% |
Ongoing Charges *** | 0.18% |
SRRI ***
|
|
SRRI date *** | 30.04.2025 |